Atlas Venture — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Kinaset Therapeutics is a biopharmaceutical company developing respiratory drug therapies.
BiotechHealthtechMedfield, US
Jamil Beg(Director of the Issuer)Tom King(Director of the Issuer)Roger Heerman(Chief Business/Operating Officer / Co-Founder)Kevin Bitterman(Director of the Issuer)Frazer Morgan(Chief Development Officer / Co-Founder)Bram Vanparys(Director of the Issuer)
Board seatKevin BittermanKevin Bitterman· per SEC Form D
HealthtechWaltham, US
Amy Schulman(Director)Tillman Gerngross(Executive Officer, Director)
Board seatJean-François Formela· per SEC Form D · $10M raise · filed Dec 2022
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.